163229-43-4

Basic information

• Product Name: CARBAMIC ACID, (2-CYANOPHENYL)-, 1,1-DIMETHYLETHYL ESTER
• Synonyms: CARBAMIC ACID, (2-CYANOPHENYL)-, 1,1-DIMETHYLETHYL ESTER;Carbamic acid, (2-cyanophenyl)-, 1,1-dimethylethyl ester (9CI);(2-Cyanophenyl)carbamic acid 1,1-dimethylethyl ester;2-(tert-Butoxycarbonylamino)benzonitrile;N-Boc-2-aminobenzonitrile
• CAS NO: 163229-43-4
• Molecular Formula: C12H14N2O2
• Molecular Weight: 218.25
• Product Categories: N-BOC
• Mol File: 163229-43-4.mol
• Article Data: 8

Chemical Properties

• Melting Point: 74-77°C
• Boiling Point: 165 °C(Press: 2 Torr)
• Appearance: /
• Density: 1.12±0.1 g/cm3(Predicted)
• PKA: 12.77±0.70(Predicted)
• CAS DataBase Reference: CARBAMIC ACID, (2-CYANOPHENYL)-, 1,1-DIMETHYLETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: CARBAMIC ACID, (2-CYANOPHENYL)-, 1,1-DIMETHYLETHYL ESTER(163229-43-4)
• EPA Substance Registry System: CARBAMIC ACID, (2-CYANOPHENYL)-, 1,1-DIMETHYLETHYL ESTER(163229-43-4)

Safety Data

• Hazard Codes: Xi,N
• Statements: 36-38-51/53
• Safety Statements: 26-61
• RIDADR: UN 3077 9 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 163229-43-4(Hazardous Substances Data)

Upstream product

• 3422-01-3 tert-butyl phenylcarbamate 
• 1122-85-6 phenyl cyanate 
• 7321-55-3 2,2-dimethylmalononitrile 
• 24424-99-5 di-tert-butyl dicarbonate 
• 36016-38-3 tert-Butyl N-hydroxycarbamate 
• 1885-29-6 anthranilic acid nitrile 
• 607-28-3 Isatin-3-oxime 
• 75-65-0 tert-butyl alcohol 
• 762241-88-3 2,3-indoledione-3-oxime O-acetate 
• 507243-19-8 (4-chloro-4,4-difluoro-3-oxo-but-1-enyl)-(2-cyano-phenyl)-carbamic acid tert-butyl ester 

Relevant articles and documents

Cleavage of O-acylates of isatin 3-oximes in the presence of alcohols [2]

-

NOVEL ANTIPARASITIC COMPOUNDS AND METHODS

Novel compounds for treating or inhibiting leishmaniasis and other parasitic protozoan diseases are disclosed herein. The compounds bind to Leishmania tubulin, induce parasite microtubule polymerization, stall Leishmania cell division, and have broad antiparasitic activity.

HEPATITIS B CORE PROTEIN ALLOSTERIC MODULATORS

ABSTRACT The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound.